{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:21:20Z","timestamp":1765380080096},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,7,17]],"date-time":"2009-07-17T00:00:00Z","timestamp":1247788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s10549-009-0475-1","type":"journal-article","created":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T00:59:58Z","timestamp":1247705998000},"page":"539-546","source":"Crossref","is-referenced-by-count":28,"title":["Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence"],"prefix":"10.1007","volume":"118","author":[{"given":"P.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Stopfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Siegfried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kaltman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. L.","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schnall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Domchek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,17]]},"reference":[{"issue":"5","key":"475_CR1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"issue":"5645","key":"475_CR2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646","journal-title":"Science"},{"issue":"19","key":"475_CR3","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2000.18.19.3360","volume":"18","author":"LJ Pierce","year":"2000","unstructured":"Pierce LJ, Strawderman M, Narod SA, Oliviotto I, Eisen A, Dawson L et al (2000) Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1\/2 mutations. J Clin Oncol 18(19):3360\u20133369","journal-title":"J Clin Oncol"},{"issue":"43","key":"475_CR4","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1038\/sj.onc.1209881","volume":"25","author":"SM Domchek","year":"2006","unstructured":"Domchek SM, Weber BL (2006) Clinical management of BRCA1 and BRCA2 mutation carriers. Oncogene 25(43):5825\u20135831","journal-title":"Oncogene"},{"issue":"2","key":"475_CR5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMcp071286","volume":"357","author":"M Robson","year":"2007","unstructured":"Robson M, Offit K (2007) Clinical practice. Management of an inherited predisposition to breast cancer [see comment]. N Engl J Med 357(2):154\u2013162","journal-title":"N Engl J Med"},{"issue":"21","key":"475_CR6","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van\u2019t Veer L, Garber JE et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346(21):1616\u20131622","journal-title":"N Engl J Med"},{"issue":"21","key":"475_CR7","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA et al (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21):1609\u20131615","journal-title":"N Engl J Med"},{"issue":"2","key":"475_CR8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","volume":"296","author":"A Finch","year":"2006","unstructured":"Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B et al (2006) Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 296(2):185\u2013192","journal-title":"JAMA"},{"issue":"30","key":"475_CR9","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","volume":"23","author":"A Eisen","year":"2005","unstructured":"Eisen A, Lubinski J, Klijn J, Moller P, Lynch HT, Offit K et al (2005) Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol 23(30):7491\u20137496","journal-title":"J Clin Oncol"},{"issue":"2","key":"475_CR10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80\u201387","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"475_CR11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","volume":"7","author":"SM Domchek","year":"2006","unstructured":"Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C et al (2006) Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol 7(3):223\u2013229","journal-title":"Lancet Oncol"},{"issue":"14","key":"475_CR12","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1158\/1078-0432.CCR-04-2424","volume":"11","author":"SR Lakhani","year":"2005","unstructured":"Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S et al (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11(14):5175\u20135180","journal-title":"Clin Cancer Res"},{"issue":"34","key":"475_CR13","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1200\/JCO.2005.02.9199","volume":"23","author":"JL Kramer","year":"2005","unstructured":"Kramer JL, Velazquez IA, Chen BE, Rosenberg PS, Struewing JP, Greene MH (2005) Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol 23(34):8629\u20138635","journal-title":"J Clin Oncol"},{"issue":"8","key":"475_CR14","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","volume":"26","author":"ND Kauff","year":"2008","unstructured":"Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE et al (2008) Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol 26(8):1331\u20131337","journal-title":"J Clin Oncol"},{"issue":"9","key":"475_CR15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-148-9-200805060-00007","volume":"148","author":"E Warner","year":"2008","unstructured":"Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148(9):671\u2013679","journal-title":"Ann Intern Med"},{"issue":"2","key":"475_CR16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD et al (2007) American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75\u201389","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"475_CR17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1148\/radiology.215.1.r00ap01267","volume":"215","author":"CK Kuhl","year":"2000","unstructured":"Kuhl CK, Schmutzler RK, Leutner CC, Kempe A, Wardelmann E, Hocke A et al (2000) Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 215(1):267\u2013279","journal-title":"Radiology"},{"issue":"9473","key":"475_CR18","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","volume":"365","author":"MO Leach","year":"2005","unstructured":"Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365(9473):1769\u20131778","journal-title":"Lancet"},{"issue":"11","key":"475_CR19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292(11):1317\u20131325","journal-title":"JAMA"},{"issue":"2","key":"475_CR20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1148\/radiol.2442060461","volume":"244","author":"CD Lehman","year":"2007","unstructured":"Lehman CD, Isaacs C, Schnall MD, Pisano ED, Ascher SM, Weatherall PT et al (2007) Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 244(2):381\u2013388","journal-title":"Radiology"},{"issue":"5","key":"475_CR21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","volume":"351","author":"M Kriege","year":"2004","unstructured":"Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5):427\u2013437","journal-title":"N Engl J Med"},{"issue":"9","key":"475_CR22","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/cncr.22603","volume":"109","author":"F Laki","year":"2007","unstructured":"Laki F, Kirova YM, This P, Plancher C, Asselain B, Sastre X, Stoppa-Lyonnet D, Salmon R, for the IC-BOCRSG IC-BOCRSG: Institut Curie -Breast Ovary Cancer Risk Study Group (2007) Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation. Cancer 109(9):1784\u20131790","journal-title":"Cancer"},{"issue":"12","key":"475_CR23","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2004.04.033","volume":"22","author":"K Metcalfe","year":"2004","unstructured":"Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E et al (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22(12):2328\u20132335","journal-title":"J Clin Oncol"},{"issue":"17","key":"475_CR24","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","volume":"91","author":"TR Rebbeck","year":"1999","unstructured":"Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L et al (1999) Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91(17):1475\u20131479","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"475_CR25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/jnci\/95.13.941","volume":"95","author":"HM Klaren","year":"2003","unstructured":"Klaren HM, van\u2019t Veer LJ, van Leeuwen FE, Rookus MA (2003) Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation [see comment]. J Natl Cancer Inst 95(13):941\u2013947","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"475_CR26","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","volume":"286","author":"MC King","year":"2001","unstructured":"King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K et al (2001) Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National surgical adjuvant breast and bowel project (NSABP-P1) breast cancer prevention trial. JAMA 286(18):2251\u20132256","journal-title":"JAMA"},{"issue":"9245","key":"475_CR27","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","volume":"356","author":"SA Narod","year":"2000","unstructured":"Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL et al (2000) Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary breast cancer clinical study group. Lancet 356(9245):1876\u20131881","journal-title":"Lancet"},{"issue":"9","key":"475_CR28","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/ijc.21536","volume":"118","author":"J Gronwald","year":"2006","unstructured":"Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M et al (2006) Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 118(9):2281\u20132284","journal-title":"Int J Cancer"},{"issue":"6","key":"475_CR29","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/1078-0432.CCR-03-1061","volume":"10","author":"WD Foulkes","year":"2004","unstructured":"Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P et al (2004) Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Cancer Res 10(6):2029\u20132034","journal-title":"Clin Cancer Res"},{"issue":"9","key":"475_CR30","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","volume":"20","author":"SR Lakhani","year":"2002","unstructured":"Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20(9):2310\u20132318","journal-title":"J Clin Oncol"},{"issue":"22","key":"475_CR31","first-page":"4987","volume":"57","author":"RB Clarke","year":"1997","unstructured":"Clarke RB, Howell A, Potten CS, Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57(22):4987\u20134991","journal-title":"Cancer Res"},{"issue":"5","key":"475_CR32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1432-0436.1998.6250221.x","volume":"62","author":"N Zeps","year":"1998","unstructured":"Zeps N, Bentel JM, Papadimitriou JM, D\u2019Antuono MF, Dawkins HJ (1998) Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth. Differentiation 62(5):221\u2013226","journal-title":"Differentiation"},{"issue":"43","key":"475_CR33","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/sj.onc.1209871","volume":"25","author":"B Evers","year":"2006","unstructured":"Evers B, Jonkers J (2006) Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects. Oncogene 25(43):5885\u20135897","journal-title":"Oncogene"},{"issue":"19","key":"475_CR34","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djg050","volume":"95","author":"WD Foulkes","year":"2003","unstructured":"Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N et al (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95(19):1482\u20131485","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"475_CR35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0959-8049(99)00337-8","volume":"36","author":"MM Tilanus-Linthorst","year":"2000","unstructured":"Tilanus-Linthorst MM, Bartels CC, Obdeijn AI, Oudkerk M (2000) Earlier detection of breast cancer by surveillance of women at familial risk. Eur J Cancer 36(4):514\u2013519","journal-title":"Eur J Cancer"},{"issue":"20","key":"475_CR36","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1001\/jama.295.20.2374","volume":"295","author":"SK Plevritis","year":"2006","unstructured":"Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE et al (2006) Cost-effectiveness of screening BRCA1\/2 mutation carriers with breast magnetic resonance imaging. JAMA 295(20):2374\u20132384","journal-title":"JAMA"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-009-0475-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0475-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:32:19Z","timestamp":1559219539000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-009-0475-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,17]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1007\/s10549-009-0475-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,17]]}}}